Recipient of federal assistance · SAN FRANCISCO, CA

EXAVIR THERAPEUTICS INC.

EXAVIR THERAPEUTICS INC. received $998K in federal grants and other assistance in FY2026, on 1 actions, −0.2% vs FY2025. It has no federal contracts in the loaded years. Since FY2023: $4M. Its largest awarding agency was National Institutes of Health ($998K).

Assistance · FY2026
$998K
New awards
1
Actions
1
Since FY2023
$4M
UEI
EV9JGJL7VVF9
Location
SAN FRANCISCO, CA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1MFY2023
  2. 1MFY2024
  3. 1MFY2025
  4. 998KFY2026

By type

  1. Grants$998K100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$998K100%

Awarding agencies

  1. National Institutes of Health$998K100%
    Department of Health and Human Services

Largest awards

  1. DEVELOPMENT OF AN ULTRA-LONG-ACTING, SELF-ADMINISTERED, DOLUTEGRAVIR-BASED TREATMENT REGIMEN FOR HIV-1 AND HIV-HBV CO-INFECTION - PROJECT…$998K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 4, 2026 – Aug 4, 2026· R44AI195119

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2023–FY2026.